Knowledge

Transcortical motor aphasia

Source 📝

172:(ICF) framework, the comprehensive assessment encompasses not only speech and language, but also impairments in body structure and function, co-morbid deficits, limitations in activity and participation, and contextual (environmental and personal) factors. The assessment can be static (current functioning) or dynamic (ongoing) and the assessment tools can be standardized or nonstandardized. Typically, the assessment for aphasia includes a gathering of a case history, a self-report from the patient, an oral-motor examination, assessment of expressive and receptive language in spoken and written forms, and identification of facilitators and barriers to patient success. From this assessment, the SLP will determine type of aphasia and the patient's communicative strengths and weaknesses and how their diagnosis may impact their overall quality of life. 184:. The SLP chooses specific therapy tasks and goals based on the speech and language abilities and needs of the individual. In general for individuals with TMoA, treatment should capitalize on their strong auditory comprehension and repetition skills and address the individual's reduced speech output and difficulty initiating and maintaining a conversation. New research in aphasia treatment is showing the benefit of the Life Participation Approach to Aphasia (LPAA) in which goals are written based on the skills needed by the individual patient to participate in specific real-life situations (i.e. communicating effectively with nurses or gaining employment). Based on the specific needs of the patient, SLPs can provide a variety of treatment activities. 45:(CVA). TMoA is generally characterized by reduced speech output, which is a result of dysfunction of the affected region of the brain. The left hemisphere is usually responsible for performing language functions, although left-handed individuals have been shown to perform language functions using either their left or right hemisphere depending on the individual. The anterior frontal lobes of the language-dominant hemisphere are essential for initiating and maintaining speech. Because of this, individuals with TMoA often present with difficulty in speech maintenance and initiation. 241:
transitioned to TMoA. All participants in the study regained full language abilities within 18 months following their stroke. This suggests a positive long-term prognosis for patients with TMoA. However, this might not be the case for all patients and more research is needed in order to solidify these findings. Another study found that prognosis of TMoA is affected by lesion size. Smaller lesions typically cause delays in speech initiation; whereas, larger lesions lead to more profound language abnormalities and difficulty with abstract language abilities.
101:, people with TMoA have deficits in initiation and maintenance of conversations, which results in reduced speech output. A person with TMoA may seldom produce utterances and typically remain silent. The utterances that they do produce are typically only one to two words long. However, in more structured and predictable interactions, individuals with TMoA tend to respond more fluently and promptly. In addition, these individuals are characterized by their attentiveness and cooperation and are often described as being task-oriented. 192:
based on the patient's experiences, opinions, or general knowledge and prompt the patient to answer with phrases or sentences. To work on more connected speech, the clinician may ask the patient to describe procedures such as making a sandwich or doing laundry. A study found that syntax training in which sentence constructions are elicited on a hierarchy of difficulty produced gains in grammatically complete utterances and utterances that successfully communicated novel and accurate information.
188:
missing and expects the patient to fill in the blank. Limited research suggests that nonsymbolic limb movement on the left side (i.e. tapping the left hand on the table) during sentence production can increase verbal initiations. The use of the left arm in left space stimulates initiation mechanisms in the right hemisphere of the brain which can also be used for language allowing individuals to produce more grammatical sentences with higher fluency and more verbal initiation.
228:
With regard to intensity and duration of treatment, studies reported maximum recovery occurred with intense weekly therapy (approximately 8 hours per week) was delivered over a 2–3 month period. Other research shows that distributed therapy may be more beneficial than high intensity therapy. More research is needed to determine which is best, but it may be found that the ideal duration and intensity of therapy is variable depending on the patient and their needs.
158:
assessment. A screening typically includes evaluation of oral motor functions, speech production skills, comprehension, use of written and verbal language, cognitive communication, swallowing, and hearing. Both the screening and assessment must be sensitive to the patient's linguistic and cultural differences. An individual will be recommended to receive a comprehensive assessment if their screening shows signs of aphasia. Under the
154:(SLP). The overall sign of TMoA is nonfluent, reduced, fragmentary echoic, and perseverative speech with frequent hesitations and pauses. Patients with TMoA also have difficulty initiating and maintaining speech. However, speech articulation and auditory comprehension remain typical. The hallmark sign of TMoA is intact repetition in the presence of these signs and symptoms. 237:
of recovery may look different depending on the type of stroke that caused the aphasia. With an ischemic stroke, recovery is greatest within the first two weeks and then diminishes overtime until the progress stabilizes. With a hemorrhagic stroke, the patient often shows little improvement in the first few weeks and then has relatively rapid recovery until they stabilize.
196:
guidelines so that the patient's responses go beyond the clinician's request and so the clinician does not do the majority of the talking. Research shows that conversation therapy can improve percent of complex utterances, the efficiency of the utterances for expressing ideas, and total time spent talking over more traditional stimulation therapy.
256:. Since the lesion that results in TMoA usually occurs in the watershed area and does not directly involve the areas of the brain responsible for general language abilities, prognosis for these patients is good overall. Other factors that determine a patient's prognosis include age, education prior to the stroke, gender, motivation, and support. 209:
Aphasia from the Aphasia Institute. In this program, the focus is put on acknowledging the patient's competence and helping them to reveal that competence. Strategies include saying “I know you know” when appropriate, using gestures to supplement messages, limiting background noise, and given sufficient time for response.
220:, taken by mouth, has provided positive outcomes during intervention for non-fluent types of aphasia, such as TMoA or adynamic aphasia. Studies have found that bromocriptine increased neural networks which assist with the initiation of speech in individuals who possess non-fluent characteristics of speech. 77:
of aphasia may present with a contiguity disorder in which they have difficulty combining linguistic elements. For dynamic aphasia, this is most apparent when the patient is asked to sequence at the sentence level whereas for other aphasias contiguity disorder can be seen at the phoneme or word level.
236:
In relation to other types of aphasia, TMoA occurs less frequently, so there is less information on its prognosis. In general, for individuals with aphasia, most recovery is seen within 6 months of the stroke or injury although more recovery may continue in the following months or years. The timeline
157:
TMoA, or any other type of aphasia, is identified and diagnosed through the screening and assessment process. Screening can be conducted by an SLP or other professional when there is a suspected aphasia. The screening does not diagnose aphasia, rather it points to the need for a further comprehensive
76:
There are some other forms of aphasia that relate to TMoA. For instance, adynamic aphasia is a form of TMoA that is characterized by sparse speech. This occurs as a result of executive functioning in the frontal lobe. Another form of aphasia related to TMoA is dynamic aphasia. Patients with this form
64:
related to language use are often affected. Executive functions relevant to language include activating language responses, controlling syntax (grammar), and narrative discourse. Difficulties in these areas can lead to supplementary deficits involving difficulties forming complex sentences, choosing
208:
Additionally, they may train the patient's communication partners to support the conversational abilities of the patient by facilitating the use of preserved cognitive and social functions. Research supports the use of various partner training programs such as Supported Conversation for Adults with
244:
Research has shown that treatment has a direct effect on aphasia outcomes. Intensity, duration and timing of treatment all need to be taken in to consideration when choosing a course of treatment and determining a prognosis. In general, greater intensity leads to greater improvement. For duration,
227:
for treatment of all types of aphasia, timing, intensity, duration, and repetition of treatment should be taken into consideration. Research has found that aphasia treatment initiated during the earlier acute post-injury phase is more effective compared to treatment initiated in the chronic phase.
199:
In order to improve the patient's abilities to functionally communicate in their natural settings, the SLP will provide strategies and techniques to enhance their success in communicative settings (i.e. supplementing speech with nonverbal communication). Research supports the use of reduced syntax
191:
To increase speech output, the clinician may provide a set of pictures and prompt the patient to describe or elaborate on the events pictured. The clinician can also provide spoken or written words and prompt the patient to use the words in a sentence. Additionally, the clinician can ask questions
204:
inhibits the patient's ability to form grammatically correct sentences, this type of treatment involves reducing these agrammatic deficits and teaching the patient to simplify linguistic structures while still conveying the message in order for language used to be more productive in conversation.
245:
longer-term treatment produces more permanent changes. As for timing, beginning treatment too early may be difficult for the system which has not recovered enough to do intensive therapy, but beginning too late may result missing the window of the opportunity in which the most change can occur.
195:
To improve conversational skills, SLPs may engage the patient in structured conversations in which supports are provided to help the patient take appropriate conversational turns, maintain the topic of conversation, and formulate appropriate sentences. Clinicians often need to provide pragmatic
187:
To improve word retrieval and initiation difficulties, clinicians may use confrontation naming in which the patient is asked to name various objects and pictures. Depending on the severity, they may also use sentence completion tasks in which the clinician says sentences with the final word(s)
240:
In a study involving eight patients with border zone lesions, all patients presented with transcortical mixed aphasia initially after the stroke. Three of these patients made a complete recovery within a few days post-stroke. For three other patients with more anterior lesions, their aphasia
249:, the brain's natural ability to reorganize itself following a traumatic event, occurs best when treatment connects simultaneous events, maintains attention, taps into positive emotion, utilizes repetition tasks, and is specific to the individual's needs. 117:
area of the left, or language-dominant, hemisphere. The anterior superior frontal lobe is known as the prefrontal cortex which is responsible for the initiation and ideation of verbal speech. The damage leaves the major language networks,
68:
The extent and location of the brain damage will impact the degree and variety of language functioning characteristics (i.e. damage deep to the frontal lobe and/or damage across multiple regions will greatly impair language). Right
849:
Kagan, Aura; Black, Sandra; Duchan, Judith; Simmons-Mackie, Nina; Square, Paula (June 2001). "Training Volunteers as Conversation Partners Using "Supported Conversation for Adults with Aphasia" (SCA): A Controlled Trial".
1331: 97:(a wide category of speech errors that are caused by aphasia). Regardless of any relative communication strengths, individuals with TMoA are typically poor conversational partners. Due to damage in the anterior superior 1112:
Flamand-Roze C, Cauquil-Michon C, Roze E, Souillard-Scemama R, Maintigneux L, Ducreux D, Adams D, Denier C (December 2011). "Aphasia in border-zone infarcts has a specific initial pattern and good long-term prognosis".
168: 85:
TMoA is classified as a non-fluent aphasia that is characterized by a significantly reduced output of speech, but good auditory comprehension. Auditory comprehension skills remain intact because the
93:
are not impaired. Individuals with TMoA also exhibit good repetition skills and can repeat long, complex phrases effortlessly and without error. However, spontaneous speech often presents with
1324: 669:
Chapey, Roberta; Duchan, Judith; Elman, Roberta; Garcia, Linda; Kagan, Aura; Lyon, Jon; Simmons-Mackie, Nina. "Life-Participation Approach to Aphasia: A Statement of Values for the Future".
960:
Berthier ML, Starkstein SE, Leiguarda R, Ruiz A, Mayberg HS, Wagner H, et al. (1991). "Transcortical aphasia: Importance of the nonspeech dominant hemisphere in language repetition".
1317: 159: 1207:
Raymer AM, Beeson P, Holland A, Kendall D, Maher LM, Martin N, et al. (February 2008). "Translational research in aphasia: from neuroscience to neurorehabilitation".
769:
Savage, Meghan; Donovan, Neila (January 2017). "Comparing linguistic complexity and efficiency in conversations from stimulation and conversation therapy in aphasia".
804:
Ruiter MB, Kolk HH, Rietveld TC (2010). "Speaking in ellipses: the effect of a compensatory style of speech on functional communication in chronic agrammatism".
684:
Raymer AM, Rowland L, Haley M, Crosson, B (2002). "Nonsymbolic movement training to improve sentence generation in transcortical motor aphasia: A case study".
349:
Zakariås, Lilla; Keresztes, Attila; Demeter, Gyula; Lukåcs, Ágnes (2013-12-01). "A specific pattern of executive dysfunctions in transcortical motor aphasia".
479:
Ardila A (2017). "Some rare neuropsychological syndromes: Central achromatopsia, BĂĄlint's syndrome, pure word-deafness, supplementary motor area aphasia".
73:, or right-sided paralysis, may coincide with TMoA if the lesion in the anterior frontal lobe is large enough and extends into the posterior frontal lobe. 995:
Kleim JA, Jones TA (February 2008). "Principles of experience-dependent neural plasticity: implications for rehabilitation after brain damage".
671:
Section III: Psychosocial/Functional Approaches to Intervention: Focus on Improving Ability to Perform Communication Activities of Daily Living
1570: 1609: 1309: 1376: 1366: 1247:
Bayles, Kathryn; Tomoeda, Cheryl (November 2010). "Neuroplasticity: Implications for Treating Cognitive-Communication Disorders".
1762: 1371: 1600: 711:
Murray LL, Heather Ray A (2001). "A comparison of relaxation training and syntax stimulation for chronic nonfluent aphasia".
384:
Gold; et al. (1997). "Adynamic Aphasia: A Transcortical Motor Aphasia with Defective Semantic Strategy Information".
265: 1638: 1619: 578: 1565: 1507: 1736: 1678: 1665: 1577: 1550: 181: 163: 151: 1605: 131: 60:; instead, the damage isolates these areas from the rest of the brain. If there is damage to the frontal lobe, 49: 42: 200:
therapy to help patients overcome the non-fluent speech and agrammatism that often occurs with TMoA. Because
1643: 1615: 1429: 427:
PhD, Alfredo Ardila (2010-03-01). "A proposed reinterpretation and reclassification of aphasic syndromes".
1711: 1685: 1582: 1490: 139: 1073:"Intensive Versus Distributed Aphasia Therapy: A Nonrandomized, Parallel-Group, Dosage-Controlled Study" 1623: 1695: 180:
Treatment for all types of aphasia, including transcortical motor aphasia, is usually provided by a
1731: 1659: 1409: 61: 57: 53: 1633: 1523: 1434: 1414: 1389: 1340: 496: 409: 127: 86: 123: 90: 1757: 1672: 1538: 1497: 1454: 1404: 1293: 1224: 1189: 1138: 1130: 1094: 1071:
Dignam J, Copland D, McKinnon E, Burfein P, O'Brien K, Farrell A, Rodriguez AD (August 2015).
1053: 1012: 977: 942: 867: 831: 786: 728: 626: 545: 444: 401: 366: 1528: 1283: 1275: 1216: 1179: 1169: 1122: 1084: 1043: 1004: 969: 932: 924: 859: 821: 813: 778: 720: 693: 618: 535: 527: 488: 436: 393: 358: 213: 246: 224: 119: 645: 1627: 1439: 1288: 1263: 1184: 1157: 1048: 1031: 937: 912: 540: 515: 114: 1279: 1220: 1008: 863: 724: 1751: 1459: 1419: 1126: 500: 217: 413: 886: 531: 98: 38: 516:"Modality-specific cognitive function of medial and lateral human Brodmann area 6" 1089: 1072: 609:
Freedman, M.; Alexander (1984). "Anatomic Basis of transcortical motor aphasia".
362: 1444: 201: 135: 70: 973: 747: 462: 928: 817: 697: 440: 110: 94: 1134: 448: 370: 1518: 1352: 782: 1297: 1228: 1193: 1142: 1098: 1057: 1016: 946: 871: 835: 790: 732: 549: 397: 1174: 981: 630: 405: 1485: 1344: 622: 65:
which words to use appropriately, and initiating speech in conversation.
1381: 492: 17: 826: 1480: 1394: 253: 41:
of the language-dominant hemisphere. This damage is typically due to
130:, unaffected. Brain injury can result from a stroke caused by left 109:
Neurological imaging has shown that TMoA is typically caused by an
1348: 169:
International Classification of Functioning, Disability and Health
252:
Other factors affecting prognosis includes location and site of
1313: 771:
International Journal of Language & Communication Disorders
212:
From a neuroscience perspective, research has found that a
52:
does not directly harm the areas of the brain involved in
1601:
Upper dorsal pontine syndrome/Raymond–CĂ©stan syndrome
887:"Communication Tools: Communicative Access & SCA" 1724: 1704: 1652: 1593: 1558: 1549: 1506: 1470: 1359: 1032:"Intensity of aphasia therapy, impact on recovery" 333:Introduction to Neurogenic Communication Disorders 852:Journal of Speech, Language, and Hearing Research 150:TMoA is diagnosed by the referring physician and 1030:Bhogal SK, Teasell R, Speechley M (April 2003). 37:, results from damage in the anterior superior 644:American Speech Language Hearing Association. 142:(TBI), or progressive neurological disorders. 1325: 113:of the anterior superior frontal lobe in the 8: 583:American-Speech-Language-Hearing Association 514:Tanaka S, Honda M, Sadato N (January 2005). 160:American Speech-Language-Hearing Association 1555: 1332: 1318: 1310: 1287: 1183: 1173: 1088: 1047: 936: 913:"Aphasia therapy on a neuroscience basis" 825: 539: 1264:"Neuroplasticity: evidence from aphasia" 748:"Rehabilitation of poststroke cognition" 746:Shigaki CL, Frey SH, Barrett AM (2014). 276: 1566:Lateral medullary syndrome/Wallenberg 1242: 1240: 1238: 1158:"Therapy efficacy in chronic aphasia" 326: 324: 322: 320: 318: 316: 314: 312: 310: 308: 306: 304: 302: 300: 7: 604: 602: 600: 573: 571: 569: 567: 565: 563: 561: 559: 474: 472: 344: 342: 298: 296: 294: 292: 290: 288: 286: 284: 282: 280: 1578:Medial medullary syndrome/Dejerine 1049:10.1161/01.STR.0000062343.64383.D0 911:PulvemĂŒller F, Bethier ML (2008). 14: 806:Neuropsychological Rehabilitation 1127:10.1111/j.1468-1331.2011.03422.x 1347:associated with lesions of the 532:10.1523/JNEUROSCI.4324-04.2005 1: 1280:10.1016/S0021-9924(00)00031-9 725:10.1016/s0021-9924(00)00043-5 481:Psychology & Neuroscience 463:"Transcortical motor aphasia" 266:Transcortical sensory aphasia 1639:Internuclear ophthalmoplegia 1090:10.1161/STROKEAHA.115.009522 363:10.1080/02687038.2013.835783 1221:10.1044/1092-4388(2008/020) 1009:10.1044/1092-4388(2008/018) 864:10.1044/1092-4388(2001/051) 182:speech-language pathologist 152:speech-language pathologist 23:Transcortical motor aphasia 1779: 331:Brookshire, R. H. (2007). 223:In order to capitalize on 15: 1737:Upper motor neuron lesion 1209:J. Speech Lang. Hear. Res 1156:Basso A, Macis M (2011). 997:J. Speech Lang. Hear. Res 929:10.1080/02687030701612213 818:10.1080/09602010903399287 698:10.1080/02687030244000239 441:10.1080/02687030802553704 166:(WHO) guidelines and the 164:World Health Organization 1606:Lateral pontine syndrome 974:10.1093/brain/114.3.1409 132:anterior cerebral artery 43:cerebrovascular accident 1763:Complications of stroke 1644:One and a half syndrome 1620:Millard–Gubler syndrome 1616:Medial pontine syndrome 783:10.1111/1460-6984.12252 335:. St. Louis, MO: Mosby. 1712:Alternating hemiplegia 617:(4). Naeser: 409–417. 398:10.1006/brln.1997.1750 140:traumatic brain injury 35:white matter dysphasia 579:"Aphasia: Assessment" 31:commissural dysphasia 1262:Thompson CK (2000). 623:10.1212/wnl.34.4.409 1732:Pseudobulbar affect 1686:Parinaud's syndrome 1677:ventral tegmentum, 1491:Parkinson's disease 1410:Hemispatial neglect 1175:10.1155/2011/313480 885:Aphasia Institute. 673:. pp. 279–289. 62:executive functions 54:language production 1664:ventral peduncle, 1634:Locked-in syndrome 1624:Foville's syndrome 1524:Dysdiadochokinesia 1435:Cortical blindness 1415:Gerstmann syndrome 1390:Expressive aphasia 1341:Signs and symptoms 493:10.1037/pne0000093 386:Brain and Language 87:arcuate fasciculus 81:Symptoms and signs 1745: 1744: 1720: 1719: 1696:Claude's syndrome 1673:Benedikt syndrome 1539:Cerebellar ataxia 1498:Thalamic syndrome 1455:Cortical deafness 1430:BĂĄlint's syndrome 1405:Receptive aphasia 357:(12): 1426–1439. 134:(ACA) occlusion, 128:arcuate fasiculus 29:), also known as 1770: 1660:Weber's syndrome 1556: 1529:Intention tremor 1334: 1327: 1320: 1311: 1302: 1301: 1291: 1259: 1253: 1252: 1244: 1233: 1232: 1204: 1198: 1197: 1187: 1177: 1153: 1147: 1146: 1121:(12): 1397–401. 1109: 1103: 1102: 1092: 1068: 1062: 1061: 1051: 1027: 1021: 1020: 992: 986: 985: 968:(3): 1409–1427. 957: 951: 950: 940: 908: 902: 901: 899: 897: 882: 876: 875: 846: 840: 839: 829: 801: 795: 794: 766: 760: 759: 743: 737: 736: 708: 702: 701: 692:(4–6): 493–506. 681: 675: 674: 666: 660: 659: 657: 656: 641: 635: 634: 606: 595: 594: 592: 590: 575: 554: 553: 543: 511: 505: 504: 476: 467: 466: 459: 453: 452: 424: 418: 417: 381: 375: 374: 346: 337: 336: 328: 214:dopamine agonist 50:watershed region 1778: 1777: 1773: 1772: 1771: 1769: 1768: 1767: 1748: 1747: 1746: 1741: 1716: 1700: 1648: 1589: 1545: 1502: 1466: 1426:Occipital lobe 1360:Cerebral cortex 1355: 1338: 1307: 1305: 1268:J Commun Disord 1261: 1260: 1256: 1249:ASHA Convention 1246: 1245: 1236: 1206: 1205: 1201: 1155: 1154: 1150: 1111: 1110: 1106: 1070: 1069: 1065: 1029: 1028: 1024: 994: 993: 989: 959: 958: 954: 910: 909: 905: 895: 893: 884: 883: 879: 848: 847: 843: 803: 802: 798: 768: 767: 763: 745: 744: 740: 719:(1–2): 87–113. 713:J Commun Disord 710: 709: 705: 683: 682: 678: 668: 667: 663: 654: 652: 643: 642: 638: 608: 607: 598: 588: 586: 577: 576: 557: 513: 512: 508: 478: 477: 470: 461: 460: 456: 426: 425: 421: 392:(57): 374–393. 383: 382: 378: 348: 347: 340: 330: 329: 278: 274: 262: 247:Neuroplasticity 234: 225:neuroplasticity 178: 148: 107: 91:Wernicke's area 83: 20: 12: 11: 5: 1776: 1774: 1766: 1765: 1760: 1750: 1749: 1743: 1742: 1740: 1739: 1734: 1728: 1726: 1722: 1721: 1718: 1717: 1715: 1714: 1708: 1706: 1702: 1701: 1699: 1698: 1693: 1692: 1691: 1683: 1682: 1681: 1670: 1669: 1668: 1656: 1654: 1650: 1649: 1647: 1646: 1641: 1636: 1631: 1613: 1603: 1597: 1595: 1591: 1590: 1588: 1587: 1586: 1585: 1575: 1574: 1573: 1562: 1560: 1553: 1547: 1546: 1544: 1543: 1542: 1541: 1533: 1532: 1531: 1526: 1521: 1512: 1510: 1504: 1503: 1501: 1500: 1495: 1494: 1493: 1488: 1483: 1477:Basal ganglia 1474: 1472: 1468: 1467: 1465: 1464: 1463: 1462: 1457: 1451:Temporal lobe 1449: 1448: 1447: 1442: 1440:Anton syndrome 1437: 1432: 1424: 1423: 1422: 1417: 1412: 1407: 1401:Parietal lobe 1399: 1398: 1397: 1392: 1384: 1379: 1374: 1369: 1363: 1361: 1357: 1356: 1339: 1337: 1336: 1329: 1322: 1314: 1304: 1303: 1254: 1234: 1215:(1): S259–75. 1199: 1148: 1115:Eur. J. Neurol 1104: 1083:(8): 2206–11. 1063: 1022: 1003:(1): S225–39. 987: 952: 923:(6): 563–599. 903: 877: 858:(3): 624–638. 841: 796: 761: 738: 703: 676: 661: 636: 596: 555: 526:(2): 496–501. 506: 487:(3): 314–324. 468: 454: 435:(3): 363–394. 419: 376: 338: 275: 273: 270: 269: 268: 261: 258: 233: 230: 177: 174: 147: 144: 126:areas and the 106: 103: 82: 79: 48:Damage in the 16:Main article: 13: 10: 9: 6: 4: 3: 2: 1775: 1764: 1761: 1759: 1756: 1755: 1753: 1738: 1735: 1733: 1730: 1729: 1727: 1723: 1713: 1710: 1709: 1707: 1703: 1697: 1694: 1690:dorsal, tumor 1689: 1688: 1687: 1684: 1680: 1676: 1675: 1674: 1671: 1667: 1663: 1662: 1661: 1658: 1657: 1655: 1651: 1645: 1642: 1640: 1637: 1635: 1632: 1629: 1625: 1621: 1617: 1614: 1611: 1607: 1604: 1602: 1599: 1598: 1596: 1592: 1584: 1581: 1580: 1579: 1576: 1572: 1569: 1568: 1567: 1564: 1563: 1561: 1557: 1554: 1552: 1548: 1540: 1537: 1536: 1534: 1530: 1527: 1525: 1522: 1520: 1517: 1516: 1514: 1513: 1511: 1509: 1505: 1499: 1496: 1492: 1489: 1487: 1484: 1482: 1479: 1478: 1476: 1475: 1473: 1469: 1461: 1460:Prosopagnosia 1458: 1456: 1453: 1452: 1450: 1446: 1443: 1441: 1438: 1436: 1433: 1431: 1428: 1427: 1425: 1421: 1420:Astereognosis 1418: 1416: 1413: 1411: 1408: 1406: 1403: 1402: 1400: 1396: 1393: 1391: 1388: 1387: 1386:Frontal lobe 1385: 1383: 1380: 1378: 1375: 1373: 1370: 1368: 1365: 1364: 1362: 1358: 1354: 1350: 1346: 1342: 1335: 1330: 1328: 1323: 1321: 1316: 1315: 1312: 1308: 1299: 1295: 1290: 1285: 1281: 1277: 1274:(4): 357–66. 1273: 1269: 1265: 1258: 1255: 1250: 1243: 1241: 1239: 1235: 1230: 1226: 1222: 1218: 1214: 1210: 1203: 1200: 1195: 1191: 1186: 1181: 1176: 1171: 1168:(4): 317–25. 1167: 1163: 1159: 1152: 1149: 1144: 1140: 1136: 1132: 1128: 1124: 1120: 1116: 1108: 1105: 1100: 1096: 1091: 1086: 1082: 1078: 1074: 1067: 1064: 1059: 1055: 1050: 1045: 1042:(4): 987–93. 1041: 1037: 1033: 1026: 1023: 1018: 1014: 1010: 1006: 1002: 998: 991: 988: 983: 979: 975: 971: 967: 963: 956: 953: 948: 944: 939: 934: 930: 926: 922: 918: 914: 907: 904: 892: 888: 881: 878: 873: 869: 865: 861: 857: 853: 845: 842: 837: 833: 828: 823: 819: 815: 812:(3): 423–58. 811: 807: 800: 797: 792: 788: 784: 780: 776: 772: 765: 762: 758:(5): 496–503. 757: 753: 749: 742: 739: 734: 730: 726: 722: 718: 714: 707: 704: 699: 695: 691: 687: 680: 677: 672: 665: 662: 651: 647: 640: 637: 632: 628: 624: 620: 616: 612: 605: 603: 601: 597: 584: 580: 574: 572: 570: 568: 566: 564: 562: 560: 556: 551: 547: 542: 537: 533: 529: 525: 521: 517: 510: 507: 502: 498: 494: 490: 486: 482: 475: 473: 469: 464: 458: 455: 450: 446: 442: 438: 434: 430: 423: 420: 415: 411: 407: 403: 399: 395: 391: 387: 380: 377: 372: 368: 364: 360: 356: 352: 345: 343: 339: 334: 327: 325: 323: 321: 319: 317: 315: 313: 311: 309: 307: 305: 303: 301: 299: 297: 295: 293: 291: 289: 287: 285: 283: 281: 277: 271: 267: 264: 263: 259: 257: 255: 250: 248: 242: 238: 231: 229: 226: 221: 219: 218:bromocriptine 215: 210: 206: 203: 197: 193: 189: 185: 183: 175: 173: 171: 170: 165: 161: 155: 153: 145: 143: 141: 137: 133: 129: 125: 121: 116: 112: 104: 102: 100: 96: 92: 88: 80: 78: 74: 72: 66: 63: 59: 58:comprehension 55: 51: 46: 44: 40: 36: 32: 28: 24: 19: 1377:PCA syndrome 1372:MCA syndrome 1367:ACA syndrome 1306: 1271: 1267: 1257: 1248: 1212: 1208: 1202: 1165: 1162:Behav Neurol 1161: 1151: 1118: 1114: 1107: 1080: 1076: 1066: 1039: 1035: 1025: 1000: 996: 990: 965: 961: 955: 920: 916: 906: 894:. Retrieved 890: 880: 855: 851: 844: 809: 805: 799: 777:(1): 21–29. 774: 770: 764: 755: 751: 741: 716: 712: 706: 689: 685: 679: 670: 664: 653:. Retrieved 649: 639: 614: 610: 587:. Retrieved 582: 523: 519: 509: 484: 480: 457: 432: 428: 422: 389: 385: 379: 354: 350: 332: 251: 243: 239: 235: 222: 211: 207: 198: 194: 190: 186: 179: 167: 156: 149: 136:brain tumors 108: 99:frontal lobe 84: 75: 67: 47: 39:frontal lobe 34: 30: 26: 22: 21: 1612:) (lateral) 1445:Pure alexia 917:Aphasiology 896:14 November 686:Aphasiology 589:October 22, 520:J. Neurosci 429:Aphasiology 351:Aphasiology 202:agrammatism 162:(ASHA) and 115:perisylvian 95:paraphasias 71:hemiparesis 1752:Categories 1508:Cerebellum 891:aphasia.ca 827:2066/72791 655:2017-11-13 272:References 124:Wernicke’s 1551:Brainstem 1519:Dysmetria 1471:Subcortex 1353:brainstem 1345:syndromes 1135:1468-1331 646:"Aphasia" 611:Neurology 501:148765359 449:0268-7038 371:0268-7038 232:Prognosis 176:Treatment 146:Diagnosis 1758:Aphasias 1653:Midbrain 1515:Lateral 1486:Dystonia 1298:11001162 1229:18230850 1194:22063820 1143:21554494 1099:26106114 1058:12649521 1017:18230848 947:18923644 872:11407567 836:20155573 791:27296243 752:Medscape 733:11322572 650:asha.org 550:15647494 414:24469031 260:See also 1628:basilar 1559:Medulla 1535:Medial 1382:Aphasia 1289:3086401 1185:5377972 982:2065258 938:2557073 631:6538298 541:6725497 406:9126422 120:Broca's 111:infarct 18:Aphasia 1481:Chorea 1395:Abulia 1343:, and 1296:  1286:  1227:  1192:  1182:  1141:  1133:  1097:  1077:Stroke 1056:  1036:Stroke 1015:  980:  945:  935:  870:  834:  789:  731:  629:  585:. 2017 548:  538:  499:  447:  412:  404:  369:  254:lesion 105:Causes 1725:Other 1705:Other 1349:brain 962:Brain 497:S2CID 410:S2CID 1610:AICA 1594:Pons 1571:PICA 1351:and 1294:PMID 1225:PMID 1190:PMID 1139:PMID 1131:ISSN 1095:PMID 1054:PMID 1013:PMID 978:PMID 943:PMID 898:2017 868:PMID 832:PMID 787:PMID 729:PMID 627:PMID 591:2018 546:PMID 445:ISSN 402:PMID 367:ISSN 122:and 89:and 27:TMoA 1679:PCA 1666:PCA 1583:ASA 1284:PMC 1276:doi 1217:doi 1180:PMC 1170:doi 1123:doi 1085:doi 1044:doi 1005:doi 970:doi 966:114 933:PMC 925:doi 860:doi 822:hdl 814:doi 779:doi 721:doi 694:doi 619:doi 536:PMC 528:doi 489:doi 437:doi 394:doi 359:doi 56:or 33:or 1754:: 1292:. 1282:. 1272:33 1270:. 1266:. 1237:^ 1223:. 1213:51 1211:. 1188:. 1178:. 1166:24 1164:. 1160:. 1137:. 1129:. 1119:18 1117:. 1093:. 1081:46 1079:. 1075:. 1052:. 1040:34 1038:. 1034:. 1011:. 1001:51 999:. 976:. 964:. 941:. 931:. 921:22 919:. 915:. 889:. 866:. 856:44 854:. 830:. 820:. 810:20 808:. 785:. 775:52 773:. 756:34 754:. 750:. 727:. 717:34 715:. 690:16 688:. 648:. 625:. 615:34 613:. 599:^ 581:. 558:^ 544:. 534:. 524:25 522:. 518:. 495:. 485:10 483:. 471:^ 443:. 433:24 431:. 408:. 400:. 388:. 365:. 355:27 353:. 341:^ 279:^ 216:, 138:, 1630:) 1626:( 1622:/ 1618:/ 1608:( 1333:e 1326:t 1319:v 1300:. 1278:: 1251:. 1231:. 1219:: 1196:. 1172:: 1145:. 1125:: 1101:. 1087:: 1060:. 1046:: 1019:. 1007:: 984:. 972:: 949:. 927:: 900:. 874:. 862:: 838:. 824:: 816:: 793:. 781:: 735:. 723:: 700:. 696:: 658:. 633:. 621:: 593:. 552:. 530:: 503:. 491:: 465:. 451:. 439:: 416:. 396:: 390:3 373:. 361:: 25:(

Index

Aphasia
frontal lobe
cerebrovascular accident
watershed region
language production
comprehension
executive functions
hemiparesis
arcuate fasciculus
Wernicke's area
paraphasias
frontal lobe
infarct
perisylvian
Broca's
Wernicke’s
arcuate fasiculus
anterior cerebral artery
brain tumors
traumatic brain injury
speech-language pathologist
American Speech-Language-Hearing Association
World Health Organization
International Classification of Functioning, Disability and Health
speech-language pathologist
agrammatism
dopamine agonist
bromocriptine
neuroplasticity
Neuroplasticity

Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.

↑